Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma

Am J Hematol. 2019 Mar;94(3):E74-E76. doi: 10.1002/ajh.25378. Epub 2018 Dec 31.

Affiliations

¹ Transplant Infectious Diseases, Westchester Medical Center, Valhalla, New York.
² Division of Hematology and Oncology, Westchester Medical Center, Valhalla, New York.

No abstract available

Publication types

Letter

MeSH terms

Aged
Bacterial Infections / blood
Bacterial Infections / diagnosis*
Bacterial Infections / immunology
Bacterial Infections / microbiology
Biomarkers / blood
C-Reactive Protein / metabolism
Diagnosis, Differential
Female
Fever / blood
Fever / diagnosis*
Fever / immunology
Fever / microbiology
Hematopoietic Stem Cell Transplantation
Humans
Length of Stay / statistics & numerical data
Male
Middle Aged
Multiple Myeloma / blood
Multiple Myeloma / immunology
Multiple Myeloma / microbiology
Multiple Myeloma / therapy*
Opportunistic Infections / blood
Opportunistic Infections / diagnosis*
Opportunistic Infections / immunology
Opportunistic Infections / microbiology
Procalcitonin / blood*
Retrospective Studies
Transplantation, Autologous

Substances

Biomarkers
Procalcitonin
C-Reactive Protein